TRENDS OF INFLUENZA VACCINE DEVELOPMENT
- 作者: Vaslllev Y.1
-
隶属关系:
- Mechnikov Research Institute of Vaccines and Sera
- 期: 卷 25, 编号 8 (2014)
- 页面: 12-14
- 栏目: Articles
- URL: https://journals.eco-vector.com/0236-3054/article/view/116005
- ID: 116005
如何引用文章
开放存取
##reader.subscriptionAccessGranted##
详细
Some perspective trends of influenza vaccine development are characterized in the review. Attention is paid to prepandemic and pandemic, virosomal, quadrivalent, cell-culture derived and universal influenza vaccines, as well as adjuvanted and live attenuated influenza vaccines.
全文:
作者简介
Yu. Vaslllev
Mechnikov Research Institute of Vaccines and Sera
Email: yury.m.vasiliev@gmail.com
Candidate of Biological Sciences
参考
- Васильев Ю.М. Адъюванты гриппозных вакцин // Журн. микробиол. -2010; 1: 100-10.
- Васильев Ю.М. Вакцины против вируса гриппа птиц // Вопр. вирусол. -2008; 6: 4-15.
- Atsmon J., Kate-Ilovitz E., Shaikevich D. et al. Safety and immunogenicity of multimeric-001-a novel universal influenza vaccine // J. Clin. Immunol. - 2012; 32 (3): 595-603.
- Beyer W., Nauta J., Palache A. et al. Immunogenicity and safety of inactivated influenza vaccines in primed populations: a systematic literature review and metaanalysis // Vaccine. - 2011; 29 (34): 5785-92.
- Beyer W., Palache A., de Jong J. et al. Cold-adapted live influenza vaccine versus inactivated vaccine: systemic vaccine reactions, local and systemic antibody response, and vaccine efficacy. A meta-analysis // Vaccine. - 2002; 20 (9-10): 1340-53.
- Monto A., Ohmit S., Petrie J. et al. Comparative efficacy of inactivated and live attenuated influenza vaccines // N. Engl. J. Med. - 2009; 361 (13): 1260-7.
- Mutsch M., Zhou W., Rhodes P. et al. Use of the inactivated intranasal influenza vaccine and the risk of Bell's palsy in Switzerland // N. Engl. J. Med. -2004; 350 (9): 896-903.
- Shaw M., Palese P. Orthomyxoviridae. In: Knipe D., Howley P. (eds.). Fields Virology / Lippincott Williams & Wilkins, 2013.
- Szymczakiewicz-Multanowska A., Lattanzi M., Izu A. et al. Safety assessment and immunogenicity of a cell-culture-derived influenza vaccine in adults and elderly subjects over three successive influenza seasons // Hum. Vaccin. Immunother. -2012; 8 (5): 645-52.
- Wack A., Baudner B., Hilbert A. et al. Combination adjuvants for the induction of potent, long-lasting antibody and T-cell responses to influenza vaccine in mice // Vaccine. - 2008; 26 (4): 552-61.
- WHO. Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness // Wkly Epid. Rec. - 2013; 88 (11): 117-25.
- WHO. Recommended composition of influenza virus vaccines for use in the 2013-2014 northern hemisphere influenza season // Wkly Epid. Rec. - 2013; 88 (10): 101-14.
- WHO. Vaccines against influenzaWHO position paper - November 2012 // Wkly Epid. Rec. - 2012; 87 (74): 461-76.
- Wright P., Neumann G., Kawaoka Y. Orthomyxoviruses. In: Knipe D., Howley P. (eds.). Fields Virology / Lippincott Williams & Wilkins, 2013.
- Yin J., Khandaker G., Rashid H. et al. Immunogenicity and safety of pandemic influenza A(H1N1) 2009 vaccine: systematic review and meta-analysis // Influenza Other Respi. Viruses. - 2011; 5 (5): 299-305.
补充文件
